Skip Navigation

Johns Hopkins Bloomberg School of Public Health

Johns Hopkins Bloomberg School of Public Health: The INFO Project

Your knowledge-sharing resource on family planning and reproductive health

Universal Navigation:
 INFO Home  |  Order  |  e-lists  |  Search Web Site  |  Contact Us  |  Press  |  Site Map  |  Espaņol/Francais

Shopping Basket

Info Reports Logo

Closing the Effectiveness Gap

 From INFO's Toolbox
June 2007
Issue No. 13		 The INFO Project • Johns Hopkins Bloomberg School of Public Health • Center for Communication Programs • 111 Market Place, Suite 310 • Baltimore, Maryland 21202, USA • 410-659-6300 • 410-659-6266 (fax) • www.infoforhealth.org • infoproject@jhuccp.org
Closing the Effectiveness Gap

Bibliography

The links in this bibliography were up-to-date as of publication. An asterisk (*) denotes an item that was particularly useful in the preparation of this issue of INFO Reports.

  1. AKBAR, J., CHAKRABORTY, J., JAHAN, N., PHILLIPS, J.F., and SATTERWAITE, A.P. Dynamics of depot medroxy progesterone acetate (DMPA) use effectiveness in the Matlab Family Planning Health Services Project. Presented at the 7th Annual Contributors Conference of Bangladesh Fertility Research Program, Dhaka, Bangladesh, Dec. 8-9, 1982.
  2. AKTUN, H., MOROY, P., CAKMAK, P., YALCIN, H.R., MOLLAMAHMUTOGLU, L., and DANISMAN, N. Depo-Provera: Use of a long-acting progestin injectable contraceptive in Turkish women. Contraception 72(1): 24-27. Jul. 2005.
  3. *ALI, M. and CLELAND, J. Contraceptive discontinuation in six developing countries: A cause-specific analysis. International Family Planning Perspectives 21(3): 92-97. Sep. 1995. (Available: http://www.guttmacher.org/pubs/journals/2109295.html)
  4. *ANCKER, J. How writers can help readers understand health screening tests. AMWA Journal 20(2): 59-61. 2005. (Available: http://www.dbmi.columbia.edu/~jsa7002/Assets/Ancker%20AMWA%202005.pdf)
  5. *ANCKER, J.S., SENATHIRAJAH, Y., KUFATKA, R., and STARREN, J.B. Design features of graphs in health risk communications: A systematic review. Journal of the American Medical Informatics Association 13(6): 608-618. Aug. 23, 2006.
  6. ANTEBY, E., REVEL, A., BEN-CHETRIT, A., ROSEN, B., TADMOR, O., and YAGEL, S. Intrauterine device failure: Relation to its location within the uterine cavity. Obstetrics and Gynecology 81(1): 112-114. Jan. 1993.
  7. * ASSOCIATION OF REPRODUCTIVE HEALTH PROFESSIONALS. Appropriate contraceptive choice and usage. Clinical Proceedings. Feb. 2000. (electronic edition)
  8. *ASSOCIATION OF REPRODUCTIVE HEALTH PROFESSIONALS. Helping your patients decide: Making informed health choices about hormonal contraception. Clinical Proceedings. Jun. 2006. (electronic edition) (Available: http://www.arhp.org/files/CPHelpingYourPatientDecide.pdf)
  9. ATUN, R.A. and SITTAMPALAM, S.R. A review of the characteristics and benefits of SMS in delivering healthcare. In: The Role of Mobile Phones in Increasing Acceptability and Efficiency in Healthcare. The Vodafone Policy Paper Series No. 4. Newbury, England, Vodafone Group, Mar. 2006. p. 20-30.
  10. BBC NEWS. Pill reminders forwarded by text <http://news.bbc.co.uk/go/pr/fr/-/2/hi/uk_news/england/leicestershire/3745944.stm> BBC News, Oct. 15, 2004.
  11. BEKSINSKA, M.E., REES, V.H., NKONYANE, T., and MCINTYRE, J.A. Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? A study of injectable and oral contraceptive use in Johannesburg. British Journal of Family Planning 24(1): 21-23. Apr. 1998.
  12. BELZER, M., YOSHIDA, E., TUCKER, D., CHUNG, K., and SANCHEZ, K. Advanced supply of emergency contraception for adolescent mothers increased utilization without reducing condom or primary contraception use. Journal of Adolescent Health 32(2): 122-123. 2003.
  13. *BERRY, D.C., RAYNOR, D.K., KNAPP, P., and BERSELLINI, E. Patients' understanding of risk associated with medication use: Impact of European Commission guidelines and other risk scales. Drug Safety 26(1): 1-11. 2003.
  14. BLANC, A.K., CURTIS, S., and CROFT, T. Does contraceptive discontinuation matter? Quality of care and fertility consequences. Chapel Hill, North Carolina, Carolina Population Center, University of North Carolina, Nov. 1999. (MEASURE Evaluation Technical Report Series No. 3) 59 p. (Available: http://www.cpc.unc.edu/measure/publications/pdf/tr-99-03.pdf)
  15. BRESLIN, M. Fearing side effects, many Turkish women choose traditional contraceptives. International Family Planning Perspectives 23(3): 139-140. Sep. 1997. (Digests) (Available: http://www.guttmacher.org/pubs/journals/2313797.html)
  16. BRIDGES.ORG. Testing the use of SMS reminders in the treatment of Tuberculosis in Cape Town, South Africa <http://www.bridges.org/publications/11/exec_summary> Bridges.org, Mar. 29, 2005.
  17. BRILL, K. Minimizing the problem of poor compliance in adolescents. Clinical experience with a modern low-dose gestodene-containing oral contraceptive. Annals of the New York Academy of Sciences 816: 457-465. Jun. 17, 1997.
  18. *BRYANT, G.D. and NORMAN, G.R. Expressions of probability: Words and numbers. New England Journal of Medicine 302(7): 411. Feb. 14, 1980.
  19. *BUDESCU, D.V. and WALLSTEN, T.S. Consistency in interpretation of probabilistic phrases. Organizational Behavior and Human Decision Processes 36(3): 391-405. Dec. 1985.
  20. *BUDESCU, D.V., WEINBERG, S., and WALLSTEN, T.S. Decisions based on numerically and verbally expressed uncertainties. Journal of Experimental Psycology: Human Perception and Performance 14(2): 281-294. May 1988.
  21. CALSYN, D., HATCH-MAILLETTE, M., DOYLE, S., COUSINS, S., and CHEN, T. Teaching condom use skills: Hands on practice is superior to observation. Presented at the XVI International AIDS Society (IAS) Conference, Toronto, Canada, Aug. 13-18, 2006. National Drug Abuse Treatment Clinical Trials Network. (Available: http://ctndisseminationlibrary.org/PPT/142.ppt)
  22. CANTO DE CETINA, T.E., CANTO, P., and ORDONEZ LUNA, M. Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception 63(3): 143-146. Mar. 2001.
  23. CHOCKALINGAM, A., BACHER, M., CAMPBELL, N., CUTLER, H., DROVER, A., FELDMAN, R., FODOR, G., IRVINE, J., RAMSDEN, V., THIVIERGE, R., and TREMBLAY, G. Adherence to management of high blood pressure: Recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control. Canadian Journal of Public Health 89(5): I5-7. Sep.-Oct. 1998.
  24. *CLELAND, J. and ALI, M.M. Reproductive consequences of contraceptive failure in 19 developing countries. Obstetrics & Gynecology 104(2): 314-320. Aug. 2004.
  25. *CRAMER, J.A. Compliance with contraceptives and other treatments. Obstetrics and Gynecology 88(3 (Suppl.)): 4S-12S. Sep. 1996.
  26. DELIVER. PipeLine 3.0. <http://portalprd1.jsi.com/portal/page?_pageid=93,3144386,93_3144434:93_3144448&_dad=portal&_schema=PORTAL&p_tab_url=DEL_ SOFTOOLS_TAB&p_le_render_type=SUBPAGE&p_le_pg_name=DEL_TOOL_SOFT_PL_PG1> John Snow, Inc., 2005.
  27. *DHAMI, M.K. and WALLSTEN, T.S. Interpersonal comparison of subjective probabilities: Toward translating linguistic probabilities. Memory and Cognition 33(6): 1057-1068. Sep. 2005.
  28. DUNCAN, G., HARPER, C., ASHWELL, E., MANT, D., BUCHAN, H., and JONES, L. Termination of pregnancy: Lessons for prevention. British Journal of Family Planning 15: 112-117. 1990.
  29. *EDWARDS, A. Flexible rather than standardised approaches to communicating risks in health care. Quality and Safety in Health Care 13(3): 169-170. Jan. 2006.
  30. *EDWARDS, A. and ELWYN, G. Presenting risk information--A review of the effects of "framing" and other manipulations on patient outcomes. Journal of Health Communication 6(1): 61-82. Jan.-Mar. 2001.
  31. *EDWARDS, A., THOMAS, R., WILLIAMS, R., ELLNER, A.L., BROWN, P., and ELWYN, G. Presenting risk information to people with diabetes: Evaluating effects and preferences for different formats by a web-based randomised controlled trial. Patient Education and Counseling 63(3): 336-349. Nov. 2006.
  32. * EDWARDS, J.E., OLDMAN, A., SMITH, L., MCQUAY, H.J., and MOORE, R.A. Women's knowledge of, and attitudes to, contraceptive effectiveness and adverse health effects. British Journal of Family Planning 26(2): 73-80. Apr. 2000.
  33. ELLERSTON, C., AMBARDEKAR, S., and HEDLEY, A. Emergency contraception: Randomized comparison of advance provision and information only. Obstetrics and Gynecology 98(4): 570-575. Oct. 2001.
  34. ELLERSTON, C., EVANS, M., and FERDEN, S. Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours. Obstetrics and Gynecology 101(6): 1168-1171. Jun. 2003.
  35. ENGENDERHEALTH. Contraceptive use and discontinuation patterns in Nepal: Norplant, IUCD, pill, and injectables. [Consolidated summary report]. New York, EngenderHealth, Sep. 2003. 19 p.
  36. FELKEY, B.G., BERGER, B.A., and KRUEGER, K.P. The pharmacist's role in treatment adherence. Part 5: The impact of pharmacy-specific technology. US Pharmacist 8: 36-39. 2005. (Available: http://uspharmacist.com/index.asp?show=article&page=8_1547.htm)
  37. *FETTING, J.H., SIMINOFF, L.A., PIANTADOSI, S., ABELOFF, M.D., DAMRON, D.J., and SARSFIELD, A.M. Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomised clinical trial: A clinical vignette study. Journal of Clinical Oncology 8(9): 1476-1482. Sep. 1990.
  38. FINGER, W.R. Evaluating family planning costs. Network 18(2). Winter 1998. (Available: http://www.fhi.org/en/RH/Pubs/Network/v18_2/index.htm)
  39. FORTIN, J.M., HIROTA, L.K., BOND, B.E., O'CONNOR, A.M., and COL, N.F. Identifying patient preferences for communicating risk estimates: A descriptive pilot study. BMC Medical Informatics and Decision Making 1: 2. Epub Aug. 1, 2001.
  40. *FOSTER, D.G., PARVATANENI, R., DE BOCANEGRA, H.T., LEWIS, C., BRADSBERRY, M., and DARNEY, P. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstetrics and Gynecology 108(5): 1107-1114. Nov. 2006.
  41. *FU, H., DAQRROCH, J.E., HAAS, T., and RANJIT, N. Contraceptive failure rates: New estimates from the 1995 National Survey of Family Growth. Family Planning Perspectives 31(2): 56-63. Mar./Apr. 1999. (Available: http://www.guttmacher.org/pubs/journals/3105699.html)
  42. GARCIA, S.N., SNOW, R., and AITKEN, I. Preferences for contraceptive attributes: Voices of women in Ciudad Juarez, Mexico. International Family Planning Perspectives 23(2): 52-58. Jun. 1997. (Available: http://www.guttmacher.org/pubs/journals/2305297.html)
  43. GARDNER, H. Multiple Intelligences: The Theory in Practice. New York, Basic Books, 1993. 320 p.
  44. *GIGERENZER, G. and EDWARDS, A. Simple tools for understanding risks: From innumeracy to insight. British Medical Journal 327(7417): 741-744. Sep. 27, 2003.
  45. GLASIER, A. and BAIRD, D. The effects of self-administering emergency contraception. New England Journal of Medicine 339(1): 1-4. Jul. 2, 1998.
  46. GLASIER, A., FAIRHURST, K., WYKE, S., ZIEBLAND, S., SEAMAN, P., WALKER, J., and LAKHA, F. Advanced provision of emergency contraception does not reduce abortion rates. Contraception 69(5): 361-366. May 2004.
  47. *GODWIN, K. Consumers' understanding of contraceptive efficacy. British Journal of Family Planning 23(2): 45-46. Jul. 1997.
  48. *GRADY, W.R., KLEPINGER, D.H., and NELSON-WALLY, A. Contraceptive characteristics: The perceptions and priorities of men and women. Family Planning Perspectives 31(4): 168-175. Jul./Aug. 1999. (Available: http://www.guttmacher.org/pubs/journals/3116899.html)
  49. GRAY, A.L., SMIT, J.A., MANZINI, N., and BEKSINSKA, M. Systematic review of contraceptive medicines: “Does choice make a difference?” Johannesburg, South Africa, Reproductive Health and HIV Research Unit, University of the Witwatersrand, South Africa, Oct. 2006. 58 p. (Final Report) (Available: http://mednet3.who.int/EML/expcom/expcom15/applications/sections/ContraChoiceReview.pdf)
  50. GRIMES, D.A., LOPEZ, L., RAYMOND, E.G., HALPERN, V., NANDA, K., and SCHULZ, K.F. Spermicide used alone for contraception. Cochrane Database of Systematic Reviews (4): CD005218. Oct. 19, 2005.
  51. *GRISAFFE, D.B. and SHELLABARGER, S. Consumer comprehension of efficacy data in four experimental over-the-counter label conditions. Drug Information Journal 31(3): 937-961. 1997.
  52. GUILLEBAUD, J. Post-it Notes and family planning. South African Journal of Obstetrics and Gynaecology 12(2): 72-73. Mar. 2006.
  53. HALPERN, V., GRIMES, D.A., LOPEZ, L., and GALLO, M.F. Strategies to improve adherence and acceptability of hormonal methods for contraception. Cochrane Database of Systematic Reviews (1): CD004317. Jan. 25, 2006.
  54. *HAMM, R.M. Selection of verbal probabilities: A solution for some problems of verbal probability expression. Organizational Behavior and Human Decision Processes 48(2): 193-223. Apr. 1991.
  55. HATCHER, R.A., TRUSSELL, J., STEWART, F., NELSON, A.L., CATES, W., and GUEST, F. Contraceptive Technology. 18th ed. New York, Ardent Media, 2004. 870 p.
  56. HEISE, L.L. Beyond acceptability: Reorienting research on contraceptive choice. Cottingham, J., ed. In: Beyond Acceptability: Users' Perspectives on Contraception. London Reproductive Health Matters for World Health Organization, 1997. p. 6-14. (Available: http://libdoc.who.int/publications/0953121003.pdf)
  57. HUBACHER, D., GOCO, N., GONZALEZ, B., and TAYLOR, D. Factors affecting continuation rates of DMPA. Contraception 60(6): 345-351. Dec. 1999.
  58. INFO PROJECT. JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH. Conclusions and recommendations from the Effectiveness Subgroup: March 23, 2004 and June 2, 2005. [Unpublished]. Jun. 2005. 2 p.
  59. *INGLIS, S. and FARNILL, D. The effects of providing preoperative statistical anaesthetic-risk information. Anaesthesia and Intensive Care 21(6): 799-805. Dec. 1993.
  60. INTERNATIONAL CONSORTIUM FOR EMERGENCY CONTRACEPTION. Emergency contraceptive pills: Medical and service delivery guidelines Washington, D.C., International Consortium for Emergency Contraception, 2003. 24 p. (2nd ed.) (Available: http://www.cecinfo.org/publications/PDFs/resources/MedicalServiceDeliveryGuidelines_Eng.pdf)
  61. INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF). IMAP statement on contraception for women with medical disorders. London, IPPF, 1999. 7 p. (Available: http://oldwww.ippf.org/medical/imap/statements/eng/pdf/1999_06a.pdf)
  62. JACKSON, R.A., SCHWARZ, E.B., FREEDMAN, L., and DARNEY, P. Advance supply of emergency contraception: Effect on use and usual contraception - A randomized trial. Obstetrics and Gynecology 102(1): 8-16. Jul. 2003.
  63. JONES, R.K., DARROCH, J.E., and HENSHAW, S.K. Contraceptive use among U.S. women having abortions in 2000-2001. Perspectives on Sexual and Reproductive Health 34(6): 294-303. Nov./Dec. 2002. (Available: http://www.guttmacher.org/pubs/journals/3429402.html)
  64. KAZI, A., KENNEDY, K.I., VISNESS, C.M., and KHAN, T. Effectiveness of the lactational amenorrhea method in Pakistan. Fertility and Sterility 64(4): 717-723. Oct. 1995.
  65. KENNEDY, K.I., LABBOK, M.H., and VANLOOK, P.F.A. Consensus statement: Lactational amenorrhea method for family planning. International Journal of Gynecology and Obestetrics 54(1): 55-57. 1996.
  66. *KESTELMAN, P. and TRUSSELL, J. Efficacy of the simultaneous use of condoms and spermicides. Family Planning Perspectives 23(5): 226-227, 232. Sep./Oct. 1991.
  67. KHAN, M.A. Side effects and oral contraceptive discontinuation in rural Bangladesh. Contraception 64(3): 161-167. Sep. 2001.
  68. KOENIG, M.A., HOSSAIN, M.B., and WHITTAKER, M. The influence of quality of care upon contraceptive use in rural Bangladesh. Studies in Family Planning 28(4): 278-289. Dec. 1997.
  69. LABBOK, M.H., HIGHT-LAUKARAN, V., PETERSON, A.E., FLETCHER, V., VON HERTZEN, H., and VAN LOOK, P.F.A. Multicenter study of the Lactational Amenorrhea Method (LAM): I. Efficacy, duration, and implications for clinical application. Contraception 55(6): 327-336. Jun. 1997.
  70. LACHOWSKY, M. and LEVY-TOLEDANO, R. Improving compliance in oral contraception: ‘The reminder card’. European Journal of Contraception and Reproductive Health Care 7(4): 210-215. Dec. 2002.
  71. LANDE, R. and RICHEY, C. Expanding services for injectables. Population Reports, Series K, No. 6, Baltimore, INFO Project, Johns Hopkins Bloomberg School of Public Health, Dec. 2006. 24 p. (Available: http://www.infoforhealth.org/pr/k6/published/k6.pdf)
  72. LAST, J.M. A Dictionary of Epidemiology. 4th ed. New York, Oxford University Press, 2001. 196 p.
  73. LEI, Z., WU, S.C., GARCEAU, R.J., JIANG, S., YANG, Q., WANG, W., and VANDER MEULEN, T.C. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception. Contraception 53(6): 357-361. Jun. 1996.
  74. LEONARD, L. Understanding the high contraceptive prevalence rates in the intervention zones of NGO partners of Groupe Pivot/Sante Population. Mali Save the Children, Dec. 2002. 30 p.
  75. *LIPKUS, I.M. and HOLLANDS, J.G. The visual communication of risk. Journal of the National Cancer Institute Monographs (25): 149-163. 1999.
  76. LOVVORN, A., NERQUAYE-TETTCH, J., GLOVER, E.K., AMANKWAH-POKU, A., HAYS, M., and RAYMOND, E. Provision of emergency contraceptive pills to spermicide users in Ghana. Contraception 61(4): 287-293. Apr. 2000.
  77. MAHMOOD, T.A., LIM, B.H., and LEES, D.A. The characteristics of and the contraceptive practice among women seeking therapeutic termination of pregnancy in the Scottish Highlands. Health Bulletin (Edinburgh) 46: 330-336. 1988.
  78. *MAN-SON-HING, M., O'CONNOR, A.M., DRAKE, E., BIGGS, J., HUM, V., and LAUPACIS, A. The effect of qualitative vs. quantitative presentation of probability estimates on patient decision-making: A randomized trial. Health Expectations 5(3): 246-255. Sep. 2002.
  79. *MAZUR, D.J. and MERZ, J.F. Patients' interpretations of verbal expressions of probability: Implications for securing informed consent to medical interventions. Behavioral Sciences and the Law 12(4): 417-426. Autumn 1994.
  80. MOOS, M.K., BARTHOLOMEW, N.E., and LOHR, K.N. Counseling in the clinical setting to prevent unintended pregnancy: An evidence-based research agenda. Contraception 67(2): 115-132. Feb. 2003.
  81. *MORENO, M. and GOLDMAN, N. Contraceptive failure rates in developing countries: Evidence from the Demographic and Health Surveys. International Family Planning Perspectives 17(2): 44-49. June 1991.
  82. ORGANON. RemindHer® user information sheet. 2004. 1 p. (Available: http://www.contraception.net/oral_pill/pdfs/CC20_uis_217RU_5v2_basic.pdf)
  83. *PALING, J. Strategies to help patients understand risks. British Medical Journal 327(7417): 745-748. Sep. 27, 2003.
  84. PÉREZ, A., LABBOK, M.H., and QUEENAN, J.T. Clinical study of the lactational amenorrhea method for family planning. Lancet 339(8799): 968-970. Apr. 18, 1992.
  85. PIAGGIO, G. and VON HERTZEN, H. Effect of delay in the administration of levonorgestrel for emergency contraception. Presented at the XVII FIGO World Congress of Gynecology and Obstetrics, Santiago, Chile, Nov. 2-7, 2003.
  86. POPULATION ACTION INTERNATIONAL. Overview: The need for security in reproductive health supplies. Washington, D.C., Interim Working Group on Reproductive Health Commodity Security, Apr. 2001. (Meeting the Challenge: Securing Contraceptive Supplies) 8 p. (Available: http://www.populationaction.org/Publications/Reports/Meeting_the_Challenge/asset_upload_file760_5487.pdf)
  87. POTTER, L., WRIGHT, S., BERRIO, D., SUAREZ, P., PINEDO, R., and CASTANEDA, Z. Oral contraceptive compliance in rural Colombia: Knowledge of users and providers. International Family Planning Perspectives 14(1): 27-31. Mar. 1988.
  88. *POTTER, L.S. How effective are contraceptives? The determination and measurement of pregnancy rates. Obstetrics and Gynecology 88(3 (Suppl.)): 13S-23S. Sep. 1996.
  89. PRATT, W.F. and BACHRACH, C.A. What do women use when they stop using the pill? Family Planning Perspectives 19(6): 257-266. Nov.-Dec. 1987.
  90. RAINE, T., HARPER, C., LEON, K., and DARNEY, P. Emergency contraception: Advance provision in a young, high-risk clinic population. Obstetrics and Gynecology 96(1): 1-7. Jul. 2000.
  91. RAMCHANDRAN, D. Developing a continuing-client strategy: How to meet changing family planning needs of clients. Population Reports, Series J, No. 55, Baltimore, INFO Project, Johns Hopkins Bloomberg School of Public Health, 2007. 24 p.
  92. RAMOS, R., KENNEDY, K.I., and VISNESS, C.M. Effectiveness of lactational amenorrhoea in prevention of pregnancy in Manila, the Philippines: Non-comparative prospective trial British Medical Journal 313(7062): 909-912. Oct. 12, 1996.
  93. RAYMOND, E.G., TRUSSELL, J., and POLIS, C.B. Population effect of increased access to emergency contraceptive pills: A systematic review. Obstetrics and Gynecology 109(1): 181-188. Jan. 2007.
  94. *REAGAN, R.T., MOSTELLER, F., and YOUTZ, C. Quantitative meanings of verbal probability expressions. Journal of Applied Psychology 74(3): 433-442. Jun. 1989.
  95. RODRIGUES, I., GROU, F., and JLY, J. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. American Journal of Obstetrics and Gynecology 184(4): 531-537. Mar. 2001.
  96. ROSENBERG, M.J., BURNHILL, M.S., WAUGH, M.S., GRIMES, D.A., and HILLARD, P.J. Compliance and oral contraceptives: A review. Contraception 52(3): 137-141. Sep. 1995.
  97. ROSENBERG, M.J. and WAUGH, M.S. Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons. American Journal of Obstetrics and Gynecology 179(3 Pt. 1): 577-582. Sep. 1998.
  98. *ROSS, J.A. Contraception: Short-term vs. long-term failure rates. Family Planning Perspectives 21(6): 275-277. Nov./Dec. 1989.
  99. ROYE, C.F. Routine provision of emergency contraception to teens and subsequent condom use: A preliminary study. Journal of Adolescent Health 28(3): 165-166. Mar. 2001.
  100. SADANA, R. and SNOW, R. Balancing effectiveness, side-effects and work: Women's perceptions and experiences with modern contraceptive technology in Cambodia. Social Science and Medicine 49(3): 343-358. Aug. 1999.
  101. SALEM, R. and SETTY, V. When contraceptives change bleeding: How family planning providers and programs can help clients choose and use suitable methods. Population Reports, Series J, No. 54, No. 54. Baltimore, INFO Project, Johns Hopkins Bloomberg School of Public Health, Aug. 2006. 24 p. (Available: http://www.infoforhealth.org/pr/j54/)
  102. *SCHAPIRA, M.M., NATTINGER, A.B., and MCHORNEY, C.A. Frequency or probability? A qualitative study of risk communication formats used in health care. Medical Decision Making 21: 459-467. 2001.
  103. SCHUNMANN, C. and GLASIER, A. Specialist contraceptive counselling and provision after termination of pregnancy improves uptake of long-acting methods but does not prevent repeat abortion: A randomized trial. Human Reproduction 21(9): 2296-2303. Sep. 2006.
  104. SHAKLEE, H. and FISCHHOFF, B. The psychology of contraceptive surprises: Cumulative risk and contraceptive effectiveness. Journal of Applied Social Psychology 20(5): 385-403. Mar. 1990.
  105. SIVIN, I., MISHELL, D.R., DIAZ, S., BISWAS, A., ALVAREZ, F., DARNEY, P., HOLMA, P., WAN, L., BRACHE, V., KIRIWAT, O., ABDALLA, K., CAMPODONICO, I., PASQUALE, S., PAVEZ, M., and SCHECHTER, J. Prolonged effectiveness of Norplant® capsule implants: A 7-year study. Contraception 61(3): 187-194. Mar. 2000.
  106. *SNOW, R., GARCIA, S., KURESHY, N., SADANA, R., SINGH, S., BECERRA-VALDIVIA, M., LANCASTER, S., MOFOKENG, M., HOFFMAN, M., and AITKEN, I. Attributes of contraceptive technology: Women's preferences in seven countries. Cottingham, J., ed. In: Beyond Acceptability: Users' Perspectives on Contraception. London, Reproductive Health Matters for World Health Organization, 1997. p. 36-48. (Available:http://whqlibdoc.int/publications/095312003.pdf)
  107. STANBACK, J., MBONYE, A., and BEKIITA, M. Contraceptive injections by community health workers in Uganda: A non-randomized trial. Bulletin of the World Health Organization. 2007. (In press)
  108. *STEINER, M. Contraceptive effectiveness: What should the counseling message be? Journal of the American Medical Association 282(15): 1405-1407. Oct. 20, 1999.
  109. STEINER, M. and DECARLO, P. What is the role of male condoms in HIV prevention? Center for AIDS Prevention Studies, University of California, San Francisco, Jan. 2005. 2 p. (Available: http://www.caps.ucsf.edu/pubs/FS/pdf/condomFS.pdf)
  110. *STEINER, M., DOMINIK, R., TRUSSELL, J., and HERTZ-PICCIOTTO, I. Measuring contraceptive effectiveness: A conceptual framework. Obstetrics and Gynecology 88(3 Suppl): 24S-30S. Sep. 1996.
  111. *STEINER, M.J., DALEBOUT, S., CONDON, S., DOMINIK, R., and TRUSSELL, J. Understanding risk: A randomized controlled trial of communicating contraceptive effectiveness. Obstetrics and Gynecology 102(4): 709-717. Oct. 2003.
  112. *STEINER, M.J., TRUSSELL, J., MEHTA, N., CONDON, S., SUBRAMANIAM, S., and BOURNE, D. Communicating contraceptive effectiveness: A randomized controlled trial to inform a World Health Organization family planning handbook. American Journal of Obstetrics and Gynecology 195(1): 85-91. Jul. 2006.
  113. TANFER, K., WIERZBICKI, S., and PAYN, B. Why are US women not using long-acting contraceptives? Family Planning Perspectives 32(4): 176-183, 191. Jul./Aug. 2000. (Available: http://www.guttmacher.org/pubs/journals/3217600.html)
  114. TASK FORCE ON POSTOVULATORY METHODS OF FERTILITY REGULATION. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 352(9126): 428-433. Aug. 8, 1998.
  115. *TIMMERMANS, D. The roles of experience and domain of expertise in using numerical and verbal probability terms in medical decisions. Medical Decision Making 14(2): 146-156. Apr.-Jun. 1994.
  116. TOLLEY, E., LOZA, S., KAFAFI, L., and CUMMINGS, S. The impact of menstrual side effects on contraceptive discontinuation: Findings from a longitudinal study in Cairo, Egypt. International Family Planning Perspectives 31(1): 15-23. Mar. 2005. (Available: http://www.guttmacher.org/pubs/journals/3101505.pdf)
  117. TROTTIER, D.A., POTTER, L.S., TAYLOR, B.A., and GLOVER, L.H. User characteristics and oral contraceptive compliance in Egypt. Studies in Family Planning 25(5): 284-292. Sep.-Oct. 1994.
  118. *TRUSSELL, J. Contraceptive failure in the United States. Contraception 70(2): 89-96. Aug. 2004.
  119. *TRUSSELL, J. The essentials of contraception: Efficacy, safety, and personal considerations. Hatcher, R.A., Trussell, J., Stewart, F., Nelson, A.L., Cates, W., Guest, F., and Kowal, D., eds. In: Contraceptive Technology. 18th ed. New York, Ardent Media, 2004. p. 221-252.
  120. *TRUSSELL, J. Contraceptive efficacy. Hatcher, R.A., Trussell, J., Nelson, A.L., Cates, W., Stewart, F.H., and Kowal, D., eds. In: Contraceptive Technology. 19th rev. ed. New York, Ardent Media, 2007. (In press)
  121. TRUSSELL, J., RODRIGUEZ, G., and ELLERTSON, C. Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception 59(3): 147-151. Mar. 1999.
  122. *TRUSSELL, J. and VAUGHAN, B. Contraceptive failure, method-related discontinuation and resumption of use: Results from the 1995 National Survey of Growth. Family Planning Perspectives 31(2): 64-72, 93. Mar.-Apr. 1999. (Available: http://www.guttmacher.org/pubs/journals/3106499.html)
  123. TRUSSELL, T.J., FADEN, R., and HATCHER, R.A. Efficacy information in contraceptive counseling: Those little white lies. American Journal of Public Health 66(8): 761-767. Aug. 1976.
  124. TWEEDIE, I., OFORI, J.K., and GLASS, W. Family planning continuation among MOH defaulters in Ghana: Draft preliminary report. Apr. 1996. 35 p. (Unpublished)
  125. U.S. PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (EMERGENCY PLAN/PEPFAR). "Phones-for-Health" connecting to a healthy future. Washington, D.C., PEPFAR, 2007. 2 p. (Available: http://www.pepfar.gov/press/80384.htm)
  126. UNDP, UNFPA, WHO SPECIAL PROGRAMME OF RESEARCH DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION, and WORLD BANK: IUD RESEARCH GROUP. The TCu 380A IUD and the frameless IUD "the FlexiGard": Interim three-year data from an international multicenter trial. Contraception 52(2): 77-83. Aug. 1995.
  127. UNITED NATIONS DEVELOPMENT PROGRAMME, UNITED NATIONS POPULATION FUND, WORLD HEALTH ORGANIZATION, and WORLD BANK. SPECIAL PROGRAMME OF RESEARCH DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. Long-term reversible contraception: Twelve years of experience with the TCu380A and TCu220C. Contraception 56(6): 341-352. Dec. 1997.
  128. UNIVERSITY OF ALBERTA. FACULTY OF MEDICINE AND DENTISTRY. Clinical epidemiology glossary. In: Evidence Based Medicine Toolkit. Edmonton, Alberta, Canada, University of Alberta, Apr. 11, 2003.
  129. VITZTHUM, V.J. and RINGHEIM, K. Hormonal contraception and physiology: A research-based theory of discontinuation due to side effects. Studies in Family Planning 36(1): 13-32. Mar. 2005.
  130. VON HERTZEN, H., PIAGGIO, G., DING, J., and CHEN, J. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: A WHO multicentre randomised trial. Lancet 360(9348): 1803-1810. Dec. 7, 2002.
  131. *WALLSTEN, T.S., BUDESCU, D.V., RAPOPORT, A., ZWICK, R., and FORSYTH, B. Measuring the vague meaning of probability terms. Journal of Experimental Psycology: General 115: 348-365. 1986.
  132. *WALSH, J. Contraceptive choices: Supporting effective use of methods. Cottingham, J., ed. In: Beyond Acceptability: Users' Perspectives on Contraception. London, Reproductive Health Matters for World Health Organization, 1997. p. 89-96. (Available:http://whqlibdoc.who.int/publications/095312003.pdf)
  133. *WALTER, F.M. and BRITTEN, N. Patients' understanding of risk: A qualitative study of decision-making about the menopause and hormone replacement therapy in general practice. Family Practice 19(6): 579-586. 2002.
  134. WILCOX, A.J., DUNSON, D.B., WEINBERG, C.R., TRUSSELL, J., and BAIRD, D.D. Likelihood of conception with a single act of intercourse: Providing benchmark rates for assessment of post-coital contraceptives. Contraception 63(4): 211-215. Apr. 2001.
  135. WOOLF, S.H., CHAN, E.C.Y., HARRIS, R., SHERIDAN, S.L., BRADDOCK, C.H., KAPLAN, R.M., KRIST, A., O'CONNOR, A.M., and TUNIS, S. Promoting informed choice: Transforming health care to dispense knowledge for decision making. Annals of Internal Medicine 143(4): 293-300. Aug. 16, 2005.
  136. * WORLD HEALTH ORGANIZATION and JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH (JHSPH). Family Planning: A Global Handbook for Providers. Baltimore, Maryland, JHSPH, 2007. (Forthcoming)
  137. WORLD HEALTH ORGANIZATION (WHO). Improving access to quality care in family planning. Medical eligbility criteria for contraceptive use. 2nd ed. Geneva, WHO, 2000.
  138. WORLD HEALTH ORGANIZATION (WHO). Safe abortion: Technical and policy guidance for health systems. Geneva, WHO, 2003. 110 p. (Available: http://www.who.int/reproductive-health/publications/safe_abortion/safe_abortion.pdf)
  139. WORLD HEALTH ORGANIZATION (WHO). Medical eligibility criteria for contraceptive use. 3rd ed. Geneva, WHO, 2004. (Available: http://www.who.int/reproductive-health/publications/mec/mec.pdf)
  140. WORLD HEALTH ORGANIZATION (WHO). Emergency contraception. Geneva, WHO, Oct. 2005. (Fact Sheet No. 244) 2 p. (Available: http://www.who.int/mediacentre/factsheets/fs244/en/index.html)
  141. WORLD HEALTH ORGANIZATION (WHO). DEPARTMENT OF REPRODUCTIVE HEALTH AND RESEARCH. Selected practice recommendations for contraceptive use. 2nd ed. Geneva, WHO, 2004. 170 p. (Available: http://www.who.int/reproductive-health/publications/spr/spr.pdf)
  142. WU, S., HU, J., and WILDEMEERSCH, D. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women. Contraception 61(2): 91-98. Feb. 2000.
Previous Next

Disclaimer: The information provided on this web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development, the U.S. Government or The Johns Hopkins University.